Highlights Of The Program

2 days business program:

Learn from real-world case studies by industry leaders.

SHOWCASING INNOVATION:

Discover the latest technology and techniques from across the industry.

leaders talk:

Hear from top-level experts about how to stay ahead in a fast-changing industry.

MULTIPLE STREAMS:

A business program that is multi-disciplinary, giving you a broad view of the industry.

SMART TECHNOLOGIES:

Explore the latest smart and AI-driven solutions, and see how they can be used in your business.

roundtable discussion:

Join talks with industry peers. Share ideas, make connections, and find new partners.

Program 2026

DAY 1 :
MONDAY, JUNE 29, 2026
08:00 - 08:50
REGISTRATION AND MORNING REFRESHMENTS
08:50 - 09:00
OPENING ADDRESS
09:00 - 09:25
SUSTAINABILITY OR COMPLIANCE? HOSPITALS DARE TO ASK: CAN WE REPROCESS MEDICAL DEVICES?
Caroline De Mooij
Rijnstate

Caroline De Mooij

Rijnstate

  • Balancing hospital sustainability goals with MDR Article 17 requirements for single-use reprocessing
  • Weighing operational costs and feasibility as hospitals question full compliance pathways
  • Exploring legal and safe alternatives for reprocessing non-critical devices under sustainable models
09:25 - 09:30
Q&A SESSION ON MDR COMPLIANCE AND SUSTAINABLE DEVICE REUSE
09:30 - 09:55
CHALLENGING CONVENTIONAL WISDOM: A COMPARATIVE STUDY BETWEEN NON-PLASMA AND PLASMA-ASSISTED METHODS IN VH₂O₂ STERILISATION
Can Ahiska
Getinge

Can Ahiska

Getinge

  • Debunking assumptions about plasma's role in VH₂O₂ sterilisation using controlled comparative analysis
  • Verifying equivalent hydrogen peroxide removal between plasma and non-plasma low-temperature methods
  • Evaluating how chamber architecture and initial H₂O₂ concentration influence sterilant load distribution
09:55 - 10:00
Q&A SESSION ON PLASMA VS. NON-PLASMA STERILISATION PERFORMANCE
10:00 - 10:25
QUALITY FIRST: CONVEYOR AUTOMATION AND DOSIMETRY IN RADIATION STERILISATION
Dirk Voessing
MSB Maschinen- & Stahlbau GmbH & Co. KG

Dirk Voessing

MSB Maschinen- & Stahlbau GmbH & Co. KG

  • Ensuring dose reproducibility through conveyor automation and precise product positioning
  • Facilitating traceability and GMP compliance with automated dosimeter handling and batch-linked data
  • Supporting validation and uptime with mechanically robust, audit-ready sterilisation systems
10:25 - 10:30
Q&A SESSION ON RADIATION STERILISATION, AUTOMATION, AND QUALITY CONTROL
10:30 - 11:00
MORNING COFFEE BREAK IN THE EXHIBIT AREA
11:00 - 11:30
PANEL DISCUSSION ON OPTIMISING STERILISATION PRACTICES IN HEALTHCARE ORGANISATIONS
Speaker ImageSpeaker ImageSpeaker ImageSpeaker Image
  • Examining regulatory pathways and fast-track options for innovative and eco-friendly sterilisation methods
  • Contrasting EtO alternatives on regulatory pathways, material compatibility, and broader clinical applicability
  • Benchmarking risk-based validation against traditional methods and their implications for patient safety
  • Charting practical pathways for SMEs to adopt alternative sterilisation without compromising safety or quality

Frank De Smedt | DyFrNd

Emily Lorcheim | ClorDiSys Solutions

Bobby Leigh | Bio Products Validation Ltd.

Enrico Allegra | Test Labs

11:30 - 11:55
STERILISATION EXPERT VERSUS PRODUCTION MANAGER: THE DUTCH MODEL
Tom Pereboom
Amsterdam UMC

Tom Pereboom

Amsterdam UMC

  • Differentiating the CSSD manager and sterilisation expert roles within the Dutch governance model
  • Grounding the dual-role concept in practical field experiences from Dutch sterilisation departments
  • Weighing patient, surgeon, and management perspectives on responsibility separation in sterile services
11:55 - 12:00
Q&A SESSION ON CSSD ROLE SEPARATION AND THE DUTCH STERILISATION MODEL
12:00 - 12:25
CHLORINE DIOXIDE GAS STERILISATION AND MATERIAL IMPACTS
Emily Lorcheim
ClorDiSys Solutions

Emily Lorcheim

ClorDiSys Solutions

  • Explaining how chlorine dioxide gas sterilises and how it differs from other common methods
  • Outlining material compatibility findings and insights from recent technical studies
  • Highlighting packaging types that work with ClO₂ and results from collaborative testing
12:25 - 12:30
Q&A SESSION ON MATERIAL AND PACKAGING EFFECTS OF CLO₂ STERILISATION
12:30 - 13:30
NETWORKING LUNCH AND VISITING THE STERILISATION EXHIBITION
13:30 - 13:55
CLEANING AND DISINFECTION VALIDATION INSIGHTS FOR REUSABLE DEVICES
Isabelle Liesenborghs
Nelson Labs

Isabelle Liesenborghs

Nelson Labs

  • Surfacing the validation challenges that manufacturers rarely see, but every IFU must reflect
  • Mapping common cleaning and disinfection failure modes back to design and material choices
  • Anchoring WFHSS reprocessing principles into the critical pre-processing steps written into the IFU
13:55 - 14:00
Q&A SESSION ON CLEANING AND DISINFECTION VALIDATION FOR REUSABLE INSTRUMENTS
14:00 - 14:25
CONTINUOUS EtO MONITORING AND AIRFLOW MANAGEMENT IN STERILISATION FACILITIES
Josh Childers
Clean Air Engineering

Josh Childers

Clean Air Engineering

  • Decoding US EPA regulatory shifts and their ripple effects on global sterilisation compliance standards
  • Quantifying EtO migration patterns through continuous air monitoring to strengthen facility containment
  • Reviewing the operational impact of HVAC systems and make-up air units on safety monitoring programmes
14:25 - 14:30
Q&A SESSION ON EtO EMISSIONS CONTROL AND FACILITY SAFETY
14:30 - 14:55
FROM TRACEABILITY TO INTELLIGENCE: HOW AI IS REDEFINING PATIENT SAFETY IN STERILE PROCESSING
Erik Lindner
Nexus AG

Erik Lindner

Nexus AG

  • Transforming reactive documentation into predictive intelligence through AI-driven traceability systems
  • Connecting OR and CSSD workflows in real time to strengthen accountability and sterilisation transparency
  • Converting sterilisation outcomes into measurable, data-powered patient safety indicators
14:55 - 15:00
Q&A SESSION ON AI-ENABLED TRACEABILITY IN STERILE PROCESSING
15:00 - 15:20
AFTERNOON COFFEE BREAK IN THE EXHIBIT AREA
15:20 - 15:45
INNOVATIONS IN EtO ABATEMENT
Margot Vandeputte
Trevi nv

Margot Vandeputte

Trevi nv

  • Introducing catalytic wet scrubbing systems that neutralise EtO emissions using water-based ambient-temperature processes
  • Applying biological filtration methods to destroy low-concentration EtO streams in high-flow sterilisation exhaust air
  • Deploying dry sorbent scrubbers with colour-change indicators for polishing EtO emissions and monitoring sorbent saturation
15:45 - 15:50
Q&A SESSION ON EtO EMISSIONS CONTROL TECHNOLOGIES
15:50 - 16:15
STERILISATION VALIDATION: THE IMPORTANCE OF A FULLY VALIDATED IFU
Enrico Allegra
Testlabs UK

Enrico Allegra

Testlabs UK

  • Exploring regulatory requirements for sterilisation validation under MDR and FDA
  • Discussing standards, methods, and insights from regulatory submission experiences
  • Reviewing common and emerging sterilisation methods, including low-temp H₂O₂
16:15 - 16:20
Q&A SESSION ON STERILISATION VALIDATION REQUIREMENTS
16:20 - 16:45
THE IMPORTANCE OF CYCLE DEVELOPMENT
Bobby Leigh
Bio Products Validation Ltd.

Bobby Leigh

Bio Products Validation Ltd.

  • Focusing on key areas of cycle development for porous loads that offer benefits to compliance, operational efficiency, and improved reliability and capacity
  • Maintaining sterility assurance through efficient and reliable equipment performance, supported by well-designed loads and cycles
  • Outlining the benefits of a robust development process in preventing patient safety risks and reducing costs, downtime, and resource burdens caused by inadequate cycle development
16:45 - 16:50
Q&A SESSION ON ROBUST CYCLE DEVELOPMENT AND STERILITY ASSURANCE
16:50 - 17:15
SELECTING THE OPTIMAL STERILISATION METHOD THROUGH RAPID PREDICTION OF LONG-TERM MATERIAL AGEING PROPERTIES
Nazli Ozdemir
Gulsine Ltd.

Nazli Ozdemir

Gulsine Ltd.

  • Comparing how various sterilisation methods drive unique degradation pathways in polymers and device materials
  • Predicting functional lifespan and failure risk using ageing physics and accelerated material modelling
  • Applying A2P2 to select optimal sterilisation methods, minimise revalidation, and improve safety and shelf life
17:15 - 17:20
Q&A SESSION ON AGEING PREDICTION AND STERILISATION SELECTION STRATEGIES
17:20 - 18:20
NETWORKING DRINKS RECEPTION
DAY 2 :
TUESDAY, JUNE 30, 2026
08:00 - 08:30
MORNING REFRESHMENTS
08:30 - 08:40
OPENING ADDRESS
08:40 - 09:05
BEYOND THE SURFACE: A NEW STANDARD FOR CLEANING AUTOCLAVES, ULTRASONIC WASHERS, AND SURGICAL INSTRUMENTS
Regina Cicarelli
Cicarelli Instrumentos Cirúrgicos

Regina Cicarelli

Cicarelli Instrumentos Cirúrgicos

  • Advancing passivation practices by replacing nitric acid with citric acid to prevent corrosion and remove free iron
  • Extending equipment lifespan by minimising pitting, staining, and chamber degradation in sterilisation systems
  • Improving environmental safety and cost efficiency through biodegradable maintenance solutions that reduce downtime
09:05 - 09:10
Q&A SESSION ON SAFE AND SUSTAINABLE MAINTENANCE IN STERILISATION DEPARTMENTS
09:10 - 09:35
HIGH RELIABILITY ORGANISATION (HRO) IN THE STERILE PROCESSING DEPARTMENT
Kevin S Ta
Kaiser Permanente

Kevin S Ta

Kaiser Permanente

  • Translating HRO principles into daily SPD practice to prevent retained instruments and case delays
  • Embedding preoccupation with failure into CSSD routines so that near misses surface before reaching the patient
  • Empowering frontline technicians to halt the line and escalate concerns regardless of role hierarchy
09:35 - 09:40
Q&A SESSION ON BUILDING A HIGH RELIABILITY CULTURE IN STERILE PROCESSING
09:40 - 10:05
REPROCESSING REUSABLE MEDICAL DEVICES IN THE LAND DOWN UNDER: AUSTRALIA'S PERSPECTIVE, CHALLENGES, AND BEST PRACTICES
Darren Martin
Bendigo Health

Darren Martin

Bendigo Health

  • Comparing Australia's reprocessing landscape to Europe's across governance and regulatory domains
  • Navigating challenges of national consistency, remote delivery, and fragmented health structures
  • Prioritising sustainability through smarter water use, reduced waste, and reusable innovations
  • Advancing reprocessing with automation, leadership focus, and infrastructure-driven quality
10:05 - 10:10
Q&A SESSION ON REPROCESSING SYSTEMS IN GEOGRAPHICALLY DIVERSE REGIONS
10:10 - 10:30
MORNING COFFEE BREAK IN THE EXHIBIT AREA
10:30 - 10:55
THE PARADIGM SHIFT IN STERILISATION: SCALABLE NITRIC OXIDE SYSTEM
Megan Frost
Sterile State

Megan Frost

Sterile State

  • Investigating nitric oxide as a novel, self-sterilising packaging and medical device solution
  • Highlighting broad material compatibility, including medical polymers and human tissue
  • Replacing ethylene oxide with a scalable NO-based gas sterilisation alternative
10:55 - 11:00
Q&A SESSION ON NITRIC OXIDE STERILISATION TECHNOLOGY
11:00 - 11:25
OPERATIONAL RISKS IN SURGICAL DEVICE MANAGEMENT: REPORTED MISSING INSTRUMENTS
Sharon Fox
University Hospitals Birmingham NHS Foundation Trust

Sharon Fox

University Hospitals Birmingham NHS Foundation Trust

  • Addressing missing instrument reporting to strengthen patient safety assurance within surgical services
  • Escalating and documenting missing instrument events through structured reporting pathways
  • Ensuring compliance in the management and reporting of missing surgical instruments
11:25 - 11:30
Q&A SESSION ON MISSING INSTRUMENT REPORTING AND PATIENT SAFETY
11:30 - 11:55
THE USE OF LASER-BASED TECHNOLOGIES WITHIN THE STERILISATION SECTOR
Christopher Ogden
Laser Partners UK

Christopher Ogden

Laser Partners UK

  • Examining research and case studies on safe laser marking of surgical instruments to enhance traceability without compromising material integrity
  • Deploying laser cleaning technologies as chemical-free ecological solutions for effective autoclave and sterilisation chamber maintenance
  • Optimising sustainability and equipment longevity through precision laser applications that reduce chemical dependency and environmental impact
11:55 - 12:00
Q&A SESSION ON LASER MARKING AND ECOLOGICAL CLEANING IN STERILISATION
12:00 - 13:00
NETWORKING LUNCH AND VISITING THE STERILISATION EXHIBITION
13:00 - 13:25
ARE DIFFERENT STERILISATION TECHNOLOGIES LEADING TO SIGNIFICANT CHANGES IN THE EXTRACTABLES PROFILE OF POLYMERS USED IN PHARMACEUTICAL PACKAGING OR IN MEDICAL DEVICES?
Frank De Smedt
DyFrNd

Frank De Smedt

DyFrNd

  • Understanding core principles of extractables and leachables studies for packaging and devices
  • Analysing the impact of sterilisation on the E&L profile of polymer-based materials
  • Conducting post-sterilisation residual testing to evaluate compliance and material safety
13:25 - 13:30
Q&A SESSION ON E&L IMPACTS OF STERILISATION TECHNOLOGIES
13:30 - 13:55
INTERPRETING AND APPLYING THE A₀ CONCEPT IN THERMAL DISINFECTION OF ENDOSCOPE REPROCESSORS
Daniel Parra
Endoval Ltd.

Daniel Parra

Endoval Ltd.

  • Explaining the A₀ concept from EN ISO 15883 and its application in 80°C thermal disinfection cycles
  • Calculating, monitoring, and verifying A₀ values in washer-disinfectors for flexible endoscopes
  • Overcoming the technical challenges to ensure consistent and compliant thermal disinfection outcomes
13:55 - 14:00
Q&A SESSION ON A₀ APPLICATION AND THERMAL DISINFECTION STANDARDS
14:00 - 14:25
INFECTION PREVENTION IN CARDIAC SURGERY: STERILISATION OF PERFUSION CIRCUITS AND EQUIPMENT
Ralph Kodjovi
Adjanou Perfusion Solution, Inc.

Ralph Kodjovi

Adjanou Perfusion Solution, Inc.

  • Strengthening perfusionists’ understanding of sterilisation protocols and contamination risks
  • Standardising sterile setup and handling techniques through targeted training and education
  • Reducing surgical site infections through improved circuit management and aseptic practices
14:25 - 14:30
Q&A SESSION ON PERFUSION STERILISATION AND INFECTION CONTROL
14:30 - 14:45
FEEDBACK AND RAFFLE DRAW
14:45 - 15:00
CLOSING REMARKS

Become a Speaker & Join the Conversation

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.